Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris

ClinicalTrials.gov ID: NCT02566369

Public ClinicalTrials.gov record NCT02566369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris

Study identification

NCT ID
NCT02566369
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Galderma R&D
Industry
Enrollment
1,208 participants

Conditions and interventions

Conditions

Interventions

  • CD5789 (trifarotene) 50μg/g cream Drug
  • Placebo cream Drug

Drug

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2015
Primary completion
Nov 13, 2017
Completion
Nov 13, 2017
Last update posted
Nov 11, 2019

2015 – 2017

United States locations

U.S. sites
86
U.S. states
30
U.S. cities
81
Facility City State ZIP Site status
Galderma Investigational Site (8258) Mobile Alabama 36608
Galderma Investigational Site (# 8530) Glendale Arizona 85308
Galderma Investigational Site (# 8511) Phoenix Arizona 85018
Galderma Investigational Site (# 8009) Hot Springs Arkansas 71913
Galderma Investigational Site (# 8355) Rogers Arkansas 72758
Galderma Investigational Site (# 8456) Beverly Hills California 90212
Galderma Investigational site (8578) Cerritos California 90703
Galderma Investigational Site (# 8526) Clovis California 93612
Galderma Investigational Site (8577) Encinitas California 92024
Galderma Investigational Site (# 8224) Fremont California 94538
Galderma Investigational Site (# 8509) Fullerton California 92835
Galderma Investigational Site (# 8507) Huntington Beach California 92647
Galderma Investigational Site (# 8425) Newport Beach California 92663
Galderma Investigational Site (# 8052) Oceanside California 92056
Galderma Investigational Site (# 8528) Santa Ana California 92701
Galderma Investigational Site (# 8160) Santa Monica California 91301
Galderma Investigational Site (# 8443) Temecula California 92592
Galderma Investigational Site (8572) Colorado Springs Colorado 80920
Galderma Investigational Site (# 8510) Englewood Colorado 80113
Galderma Investigational Site (# 8370) Boynton Beach Florida 33437
Galderma Investigational Site (# 8543) Fort Lauderdale Florida 33316
Galderma Investigational Site (8143) Miami Florida 33175
Galderma Investigational site (8259) Miramar Florida 33027
Galderma Investigational Site (# 8522) North Miami Beach Florida 33162
Galderma Investigational Site (# 8531) Orange Park Florida 32073
Galderma Investigational Site (8502) Orlando Florida 32814
Galderma Investigational Site (#8213) Ormond Beach Florida 32174
Galderma Investigational Site (# 8529) Sanford Florida 32771
Galderma Investigational Site (# 8455) St. Petersburg Florida 33708
Galderma Investigational Site (# 8523) Tampa Florida 33609
Galderma Investigational Site (# 8126) West Palm Beach Florida 33401
Galderma Investigational Site (#8189) Snellville Georgia 30078
Galderma Investigational Site (8582) Idaho Falls Idaho 83404
Galderma Investigational Site (# 8367) Arlington Heights Illinois 60005
Galderma Investigational Site (8191) Chicago Illinois 60611
Galderma Investigational site (8571) Darien Illinois 60561
Galderma Investigational Site (8575) Oakbrook Terrace Illinois 60180
Galderma Investigational Site (# 8366) Plainfield Indiana 46168
Galderma Investigational Site (# 8532) Overland Park Kansas 66215
Galderma Investigational Site (# 8069) Louisville Kentucky 40202
Galderma Investigational Site (8092) Louisville Kentucky 40217
Galderma Investigational Site (8545) Owensboro Kentucky 42301
Galderma Investigational Site (8457) Monroe Louisiana 71203
Galderma Investigational site (8580) New Orleans Louisiana 70130
Galderma Investigational Site (# 8012) Glenn Dale Maryland 20769
Galderma Investigational Site (# 8525) Rockville Maryland 20850
Galderma Investigational Site (# 8541) Quincy Massachusetts 02169
Galderma Investigational Site (#8512) Bay City Michigan 48706
Galderma Investigational Site (8574) Clarkston Michigan 48346
Galderma Investigational Site (#8033) Clinton Township Michigan 48038
Galderma Investigational Site (8129) Fort Gratiot Michigan 48059
Galderma Investigational Site (# 8226) Warren Michigan 48088
Galderma Investigational Site (# 8521) Saint Joseph Missouri 64506
Galderma Investigational Site (#8027) St Louis Missouri 63141
Galderma Investigational Site (# 8544) Lincoln Nebraska 68502
Galderma Investigational Site (# 8108) Las Vegas Nevada 89144
Galderma Investigational Site (#8420) Newington New Hampshire 03801
Galderma Investigational Site (# 8506) Hackensack New Jersey 07601
Galderma Investigational Site (#8500) Brooklyn New York 11203
Galderma Investigational Site (8524) East Setauket New York 11733
Galderma Investigational Site (8568) New York New York 10022
Galderma Investigational Site (8585) New York New York 10028
Galderma Investigational Site (8279) New York New York 10075
Galderma Investigational Site (8566) Charlotte North Carolina 28277
Galderma Investigational Site (#8514) Hickory North Carolina 28602
Galderma Investigational Site (# 8195) Beachwood Ohio 44122
Galderma Investigational Site (# 8016) Cincinnati Ohio 45255
Galderma Investigational site (8595) Dublin Ohio 43016
Galderma Investigational Site (8188) Hershey Pennsylvania 17033
Galderma Investigational site (8353) Yardley Pennsylvania 19067
Galderma Investigational Site (# 8369) Charleston South Carolina 29414
Galderma Investigational Site (# 8117) Knoxville Tennessee 37917
Galderma Investigational Site (# 8515) Nashville Tennessee 37203
Galderma Investigational Site (# 8542) Arlington Texas 76017
Galderma Investigational Site (#8513) Austin Texas 78705
Galderma Investigational site (8579) Beaumont Texas 77701
Galderma Investigational Site (# 8245) Dallas Texas 75231
Galderma Investigational Site (8183) Houston Texas 77030
Galderma Investigational site (8576) Katy Texas 77949
Galderma Investigational Site (8583) Murphy Texas 75094
Galderma Investigational Site (8567) San Antonio Texas 78213
Galderma Investigational site (8433) San Antonio Texas 78218
Galderma Investigational site (8329) San Antonio Texas 78229
Galderma Investigational site (8106) Layton Utah 84041
Galderma Investigational Site (# 8214) Salt Lake City Utah 84117
Galderma Investigational Site (# 8351) Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02566369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 11, 2019 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02566369 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →